Clinical Trials Directory

Trials / Completed

CompletedNCT01578382

Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)

Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU): A Comparison of Martorell HYTILU, Calciphylaxis and Venous Ulcer (Control)

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Martorell hypertensive ischemic leg ulcer is a severe type of skin necrosis (skin infarction) which occurs in long-term hypertensive subjects. Calciphylaxis (calcific uremic arteriolopathy) is a severe type of skin necrosis (skin infarction) which occurs in subjects with end-stage kidney disease or after kidney transplantation.

Detailed description

Comparative study including * 20 consecutive patients with Martorell HYTILU * 10 consecutive patients with Calciphylaxis (calcific uremic arteriolopathy) * 20 patients with venous ulcer The following parameters are measured in the blood serum: White blood count; c-reactive protein; creatinine; calcium (total); free (ionized) calcium; phosphate; albumin; 25-hydroxyvitamin-D; 1-25-dihydroxyvitamin-D; homocysteine; cystatin C alphafetoin, osteoprotegerin; fibroblast growth factor 23 (FGF-23); globular arrest 1 (GLA-1) The following parameters are measured in samples of diseased (necrobiotic) skin: alphafetoin, osteoprotegerin; fibroblast growth factor 23 (FGF-23); globular arrest 1 (GLA-1)

Conditions

Timeline

Start date
2011-09-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2012-04-16
Last updated
2021-06-18

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01578382. Inclusion in this directory is not an endorsement.